-
Experimental Ebola vaccines elicit year-long immune response
europeanpharmaceuticalreview
May 06, 2019
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year…
-
FDA Approves Dengvaxia
drugs
May 06, 2019
FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions.
-
Big pharma can only see the benefit of R&D for wealthy markets
theguardian
May 05, 2019
At the end of April, health workers in Malawi, Ghana and Kenya began rolling out the first and so far only vaccine proved to protect against malaria.
-
Gene-based Zika vaccine is safe and immunogenic in healthy adults
europeanpharmaceuticalreview
May 05, 2019
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
-
Single-dose vaccine could provide faster protection against cholera
europeanpharmaceuticalreview
May 05, 2019
Researchers have shown that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks of cholera…
-
Heroin vaccine blocks lethal overdose
europeanpharmaceuticalreview
May 05, 2019
Scientists have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug…
-
$100 million is to be invested to increase vaccine manufacturing in US
europeanpharmaceuticalreview
May 05, 2019
A $100 million investment has been made to support long-term vaccine manufacturing capabilities in the US.
-
Novel colorectal cancer vaccine shows positive phase I results
europeanpharmaceuticalreview
May 05, 2019
A new vaccine for colorectal cancer has proven to be safe in a small sample of human subjects, opening the way for the next phase of testing.
-
Heroin vaccine could tackle opioid addiction
europeanpharmaceuticalreview
April 30, 2019
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
-
BM32 vaccine developed against rhinitis
europeanpharmaceuticalreview
April 30, 2019
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis…